Aspirin helps lower risk of death from colon cancer, study finds

08/12/2009 | Reuters

A U.S. study found that colon cancer patients who regularly take aspirin have a lower risk of disease recurrence, are less likely to die from colon cancer and are less likely to die from any cause. "These results suggest that aspirin may influence the biology of established colorectal tumors in addition to preventing their occurrence," one researcher said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI